early detection
Gene Variant Test Shows Promise for Improving Accuracy of CA19-9 for Pancreatic Cancer Detection
Premium
Investigators are assessing performance in a prospective cohort with hopes that the method can be used to complement currently used imaging surveillance.
Biological Dynamics Partners With Pancreatic Cancer Consortium On Early Detection Study
The firm aims to recruit at least 1,000, and up to 5,000, individuals at an elevated risk for pancreatic cancer, comparing its test to standard-of-care surveillance.
The firm is offering its epiCervix assay in the US as a laboratory-developed test to be used alongside human papillomavirus screening.
MiRxes Gets $50M in Series D Funding, Applies to Hong Kong Limited Stock Exchange
The firm plans to use the investment to scale adoption and penetration of its flagship stomach cancer blood test in Asia-Pacific markets and to develop other assays.
Freenome, Walgreens Partner to Diversify Cancer Early Detection Studies
The pharmacy firm will lend its recruitment technology and infrastructure to enroll a more diverse patient population, beginning with Freenome's Sanderson Study.